Get the Daily Brief
Latest Biotech News
AI Enhances Naloxone Co-prescribing to Tackle Opioid Crisis
Amid the escalating opioid epidemic, healthcare providers are adopting artificial intelligence-based clinical decision support systems to improve naloxone co-prescribing in hospitals. This...
New Alzheimer’s Drug Leqembi Gains FDA Approval for Home Use
The FDA has approved an injectable formulation of Leqembi, developed by Eisai and Biogen, facilitating weekly maintenance dosing that can be administered in patients' homes. This approval marks a...
Lilly Narrows Oral GLP-1 Trials, Focuses on Key Program After Mid-Stage Cuts
Eli Lilly has discontinued two of three mid-stage clinical trials of its oral GLP-1 diabetes drug candidate naperiglipron citing strategic business reasons. The remaining phase 2 trial targets...
Royalty Pharma Secures $950 Million Deal for Amgen’s Lung Cancer Immunotherapy
Royalty Pharma has acquired royalty interests in Amgen’s Imdelltra (tarlatamab-dlle), an FDA-accelerated bispecific T-cell engager approved for extensive-stage small cell lung cancer. The $950...
AI Detects Covert Consciousness in Comatose Patients via Facial Microexpressions
Researchers developed an AI-enabled system named SeeMe that analyzes subtle facial muscle movements in comatose brain injury patients to detect consciousness unperceivable by standard clinical...
Novel Antimicrobial Compounds Discovered in Venoms Using Artificial Intelligence
Researchers applied AI algorithms to analyze venom proteomes from snakes, spiders, and scorpions, uncovering new potent antimicrobial peptides with rapid and specific antibacterial effects. This...
CRISPR Editing Efficiency Tripled by DNA-Wrapped Nanoparticles
Scientists have enhanced CRISPR-Cas9 genome editing precision and efficiency by developing DNA-wrapped nanoparticle delivery platforms that increase targeted DNA integration rates in diverse cell...
Sino Biological’s One-Stop Solutions Streamline CAR T-cell Therapy Development
With CAR T-cell therapies becoming mainstream in oncology and autoimmune diseases, Sino Biological offers an integrated platform of validated bioreagents supporting all phases of CAR T-cell...
Teva Scores FDA Nod for First Generic Weight Loss GLP-1 Drug
Teva Pharmaceuticals has secured FDA approval for a generic version of liraglutide, the first generic glucagon-like peptide-1 (GLP-1) agonist indicated for adult and adolescent weight management....
MRI Radiomics Correlates with Tumor Microenvironment in Cervical Cancer
A multidisciplinary research team has demonstrated significant associations between advanced MRI radiomic features and the biological characteristics of cervical cancer tumor microenvironments. By...
Alzheimer's Treatment Moves Home with FDA Nod
The FDA has approved a new injectable form of Eisai and Biogen's Alzheimer's drug Leqembi, enabling weekly maintenance dosing that patients can receive at home. This marks a significant regulatory...
Oral GLP-1 Therapies Face Clinical and Market Shifts
Eli Lilly has strategically terminated two of the three ongoing phase 2 trials of its oral GLP-1 candidate naperiglipron citing 'strategic business reasons,' while continuing a pivotal trial...
Advances in Cancer Therapeutics and Biomarkers
Several breakthroughs in oncology were reported including the identification of CBFA2T3 as a prognostic biomarker in lung adenocarcinoma, the unveiling of SC134-deruxtecan, an antibody-drug...
Artificial Intelligence Enhances Biomedical and Clinical Applications
In cutting-edge AI developments, UCLA engineers introduced a wearable noninvasive brain-computer interface co-pilot system that deciphers user intent, advancing neurotechnology applications....
Metabolic and Endocrine Research Insights
Recent studies have advanced understanding in metabolic diseases including insulin resistance surrogates as predictors of diabetic kidney disease and cholesterol ratios associated with insulin...
Innovations in Oncology Diagnostic and Treatment Strategies
Progress in oncology includes new AI-enabled diagnostic tools such as OncoMet deep learning for esophageal cancer progression and fecal miR-92a biomarker screening for colorectal cancer. CAR...
Biotech Funding and Market Movements
August saw notable funding rounds in health technology, reflecting increased investment in innovative biotech ventures. Royalty Pharma acquired an up-to $950 million royalty interest in Amgen’s...
Neuroscience and Brain Function Discoveries
New research is uncovering mechanisms underlying brain-related diseases and functions. Studies revealed unique brain signaling differentiating Parkinson’s disease from essential tremor, links...
Breakthroughs in Regenerative and Stem Cell Therapies
Emerging studies report potential of umbilical cord mesenchymal stem cells combined with melatonin in treating premature ovarian failure, and bone marrow stem cell-derived exosomes promoting...
Climate Change and Environmental Impact Studies
A study in African cities highlights expanding urban gullies caused by inadequate drainage and rapid urbanization, displacing thousands and threatening infrastructure. Researchers warn this hazard...